Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)
PHASE1
This is an open-label, multi-center, randomized, Phase 1b, adaptive, clinic...
Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors
PHASE2
This is an open-label, multicenter, basket trial Phase II study to evaluate...
Status
Terminated
Location
University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center
A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma
PHASE1
This is an open-label, multicenter, Phase Ib study to evaluate the safety a...
A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)
PHASE1
This first-in-human, open-label, multicenter, Phase Ia/Ib, adaptive, multip...